The expression of sphingosine kinase-1 in head and neck carcinoma

Cells Tissues Organs

Volumn 192, Issue 5, 2010, Pages 314-324

  Facchinetti, María M ^a   Gandini, Norberto A ^a   Fermento, María E ^a   Sterin Speziale, Norma B ^c   Ji, Youngmi ^d   Patel, Vyomesh ^e   Gutkind, J Silvio ^e   Rivadulla, Maria G ^b   Curino, Alejandro C ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

^b Leonidas Lucero Municipal Hospital   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Oral cancer; Sphingolipids; Sphingosine kinase; Tissue microarray

Indexed keywords

MESSENGER RNA; SPHINGOSINE KINASE 1;

ARTICLE; CANCER SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MICROARRAY ANALYSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; SPHINGOLIPIDS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77958025091     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318173     Document Type: Article

References (63)

1. Aguero, M.F., M.M. Facchinetti, Z. Sheleg, A.M. Senderowicz (2005) Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Res 65: 3364-3373.
2. Alvarez, S.E., S. Milstien, S. Spiegel (2007) Auto-crine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18: 300-307.
3. Bektas, M., C.E. Orfanos, C.C. Geilen (2000) Different vitamin D analogues induce sphin-gomyelin hydrolysis and apoptosis in the human keratinocyte cell line HaCaT. Cell Mol Biol (Noisy-le-grand) 46: 111-119.
4. Bukholm, I.K., J.M. Nesland, R. Karesen, U. Ja-cobsen, A.L. Borresen-Dale (1997) Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild type p53. Int J Cancer 73: 38-41
5. Davies, S.L., J. Bozzo (2006) Spotlight on tNOX: a tumor-selective target for cancer therapies. Drug News Perspect 19: 223-225.
6. Facchinetti, M.M., A. De Siervi, D. Toskos, A.M. Senderowicz (2004) UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular sig na l-reg u lated k i na se pat hway. Cancer Res 64: 3629-3637.
7. Facchinetti, M.M., F. Leocata Nieto, M.G. Márquez, N. Sterin-Speziale (2008) Stratification of sphingosine kinase-1 expression and activity in rat kidney. Cells Tissues Organs 188: 388-392.
8. Fillies, T., M. Woltering, B. Brandt, J.P. Va n Di-est, R. Werkmeister, U. Joos, H. Buerger (2007) Cell cycle regulating proteins p21 and p27 in prog nosis of oral squamous cell carcinomas. Oncol Rep 17: 355-359.
9. French, K.J., J.J. Upson, S.N. Keller, Y. Zhuang, J.K. Yun, C.D. Smith (2006) Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 318 : 596-603.
10. Futerman, A.H., Y.A. Hannun (2004) The complex life of simple sphingolipids. EMBO Rep 5: 777-782.
11. Gamble, J.R., P. Xia, C.N. Hahn, J.J. Drew, C.J. Drogemuller, D. Brown, M.A. Vadas (2006) Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumor effects. Int J Cancer 118 : 2412-2420.
12. Gorgoulis, V., V. Zoumpourlis, G. Rassidakis, A. Karameris, C. Barbatis, D.A. Spandidos, C. Kittas (1995) Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index. Vir-chows Arch 426: 339-344.
13. Greene, F.L., D.L. Page, I.D. Fleming, A. Fritz, C.M. Balch (2002) AJCC Cancer Staging Manual, ed 6. New York, Springer.
14. Hait, N.C., C.A. Oskeritzian, S.W. Paugh, S. Milstien, S. Spiegel (2006) Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026.
15. Hait, N.C., J. Allegood, M. Maceyka, G.M. Strub, K.B. Harikumar, S.K. Singh, C. Luo, R. Mar-morstein, T. Kordula, S. Milstien, S. Spiegel (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325: 1254-1257.
16. Hammer, S., B. Sauer, I. Spika, C . Schraut, B. K le-user, M. Schafer-Korting (2004) Glucocorti-coids mediate differential anti-apoptotic effects in human fibroblast and keratinocytes via sphingosine-1-phosphate formation. J Cell Biochem 91: 840-851.
17. Hannun, Y.A., L.M. Obeid (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
18. Heck, M.M., W.C. Earnshaw (1986) Topoisom-erase II: a specific marker for cell proliferation. J Cell Biol 103: 2569-2581.
19. Herst, P.M., T. Petersen, P. Jerram, J. Baty, M.V. Berridge (2007) The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Biochem Pharmacol 74:1587-1595.
20. Herzinger, T., B. K leuser, M . Schäfer-Kort ing, H.C. Korting (2007) Sphingosine-1-phos-phate signaling and the skin. Am J Clin Der-matol 8: 329-336.
21. Higo, M., K. Uzawa, T. Kawata, Y. Kato, Y. Kou-zu, N. Yamamoto, T. Shibahara, J.E. Mizoe, H. Ito, H. Tsujii, H. Tanzawa (2006) Enhancement of SPHK1 in vitro by carbon ion ir rad iat ion in oral squamous cel l carcinoma. Int J Radiat Oncol Biol Phys 65: 867-875.
22. Hla, T. (2003) Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 47: 401-407.
23. 2+ signaling. J Invest Dermatol 128: 2166-2178.
24. Igarashi, N., T. Okada, S. Hayashi, T. Fujita, S. Jahangeer, S. Nakamura (2003) Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278: 46832-46839.
25. Jemal, A., L.X. Clegg, E. Ward, La Ries, X. Wu, P.M. Jamison, P.A. Wingo, H.L. Howe, R.N. Anderson, B.K. Edwards (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101: 3-27.
26. Jemal, A., R. Siegel, E. Ward (2007) Cancer statistics. CA Cancer J Clin 57: 43-66.
27. Johnson, K.R., K.P. Becker, M.M. Facchinetti, Y.A. Hannun, L.M. Obeid (2002) PKC-de-pendent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phos-phate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277: 35257-35262.
28. Johnson, K.R., K.Y. Johnson, H.G. Crellin, B. Ogretmen, A.M. Boylan, R.A. Harley, L.M. Obeid (2005) Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 53: 1159-1166.
29. Kapranos, N., G.P. Stathopoulos, L. Manolopou-los, et al (2001) p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res 21: 521-528.
30. Kamsteeg, M., T. Rutherford, E. Sapi, B. Hancza-ruk, S. Shahabi, M. Flick, D. Brown, G. Mor (2003) Phenoxodiol-an isoflavon analogue-induces apoptosis in chemo-resistant ovarian cancer cells. Oncogene 22: 2611-2620.
31. Karahataya, S., K. Thomasa, S. Koybasia, C.E. Senkala, S. El Ojeimyc, X. Liu, J. Bielawski, T.A. Day, M.B. Gillespie, D. Sinha, J.S. Nor-ris, Y.A. Hannun, B. Ogretmen (2007) Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett 256: 101-111.
32. Kawamori, T., W. Osta, K.R. Johnson, B.J. Pettus, J. Bielawski, T. Tanaka, M.J. Wargovich, B.S. Reddy, Y.A. Hannun, L.M. Obeid, D. Zhou (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J 20: 386-388.
33. Kohama, T., A. Olivera, L. Edsall, M.M. Nagiec, R. Dickson, S. Spiegel (1998) Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273: 23722-23728.
34. Kohno, M., M. Momoi, M.I. Oo, J.H. Paik, Y.M. Lee, K. Venkataraman, J. Ai, A.P. Ristimaki, H. Fyrst, H. Sano, D. Rosenberg, J.D. Saba, R.I. Proia, T. Hla (2006) Intracellular role for sphingosine kinase in intestinal adenoma proliferation. Mol Cell Biol 26: 7211-7223.
35. Li, W., C.H. Thompson, C.J. O'Brien, E.B. McNeil, R.A. Scolyer, YE. Cossart, M.J. Veness, D.M. Walker, G.J. Morgan, B.R. Rose (2003) Human papillomavirus positivity predicts favourable outcomefor.squamous carcinoma of the tonsil. Int J Cancer 106: 553-558.
36. Liu, H., M. Sugiura, V.E. Nava, L.C. Edsall, K. Kono, S. Poulton, S. Milstien, T. Kohama, S. Spiegel (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275: 19513-19520.
37. Liu, H, R.E. Toman, S.K. Goparaju, M. Macey-ka, V.E. Nava, H. Sankala, S.G Payne, M. Bektas, I. Ishii, J. Chun, S. Milstien, S. Spiegel (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278: 40330-40336.
38. -AACT method. Methods 25:402-408.
39. Manggau, M., D.S. Kim, L. Ruwisch, R. Vogler, H.C. Korting, M. Schäfer-Korting, B. Kleus-er (2001) 1a,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 117: 1241-1249.
40. Markovits, J., C. Linassier, P. Fosse, J. Couprie, J. Pierre, A. Jacquemin-Sablon, J.M. Saucier, J.B. Le Pecq, A.K. Larsen (1989) Inhibitory effects of the tyrosine kinase inhibitor genis-tein on mammalian DNA topoisomerase II. Cancer Res 49: 5111-5117.
41. Miller, A.V., S.E. Alvarez, S. Spiegel, D.A. Leb-man (2008) Sphingosine kinases and sphin-gosine-1-phosphate are critical for TGFfS-in-duced ERK1/2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol 28: 4142-4151.
42. Miracca, E.C., L.P. Kowalski, M.A. Nagai (1999) High prevalence of p16 genetic alterations in head a nd neck tumours. Br J Cancer 81: 677-683
43. Molinolo, A.A., S.M. Hewitt, P. Amornphi-moltham, S. Keelawat, S. Rangdaeng, A. Meneses García, A.R. Raimondi, R. Jufe, M. Itoiz , Y. Gao, D. Saranat h, G.S. Ka leebi, G.H. Yoo, L. Leak, E.M. Myers, S. Shintani, D. Wong, H.D. Massey, W.A. Yeudall, F. Lonar-do, J. Ensley, J.S. Gutkind (2007) Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13: 4964-4973.
44. Morré, D.J., P.J. Chueh, K. Yagiz, A. Balicki, C. Kim, D.M. Morré (2007) ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol Res 16 : 299-312.
45. Murate, T., Y. Banno, K. T-Koizumi, K. Wata-nabe, N. Mori, A. Wada, Y. Igarashi, A. Tak-agi, T. Kojima, H. Asano, Y. Akao, S. Yoshi-da, H. Saito, Y. Nozawa (2001) Cell type-specific localization of sphingosine ki-nase 1a in human tissues. J Histochem Cyto-chem 49: 845-855.
46. Nemoto, S., M. Nakamura, Y. Osawa, S. Kono, Y. Itoh, Y. Okano, T. Murate, A. Hara, H. Ueda, Y. Nozawa, Y. Banno (2009) Sphingosine ki-nase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ce-ramide accumulation and Akt activation. J Biol Chem 284: 10422-10432.
47. Olivera, A., T. Kohama, L. Edsall, V. Nava, O. Cuvillier, S. Poulton, S. Spiegel (1999) Spin-gosine kinase expression increases intracel-lular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147: 545-558.
48. Pitson, S.M., R.J. D'andrea, L. Vandeleur, P.A. Moretti, P. Xia, J.R. Gamble, M.A. Vadas, B.W. Wattenberg (2000) Human sphingo-sine kinase: purification, molecular cloning and characterization of the native and re-combinant enzymes. Biochem J 350: 429-41.
49. Radin, N.S (2003) Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem J 371: 243-256.
50. Ruckhäberle, E., A. Rody, K. Engels, R. Gaetje, G. Von Minckwitz, S. Schiffmann, S. Grösch, G. Geisslinger, U. Holtrich, T. Karn, M. Kaufmann (2007) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112 : 41-52.
51. Sankala, H.M., N.C. Hait, S.W. Paugh, D. Shida, S. Lépine, L.W. Elmore, P. Dent, S. Milstien, S. Spiegel (2007) Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubi-cin. Cancer Res 67: 10466-10474.
52. Schüppel, M., U. Kürschner, U. Kleuser, M. Schäfer- Korting, B. Kleuser (2008) Sphingo-sine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol 128: 1747-1756.
53. Schweigerer, L., K. Christeleit, G. Fleischmann, H. Adlercreutz, K. Wahala, T. Hase, M. Schwab, R. Ludwig, T. Fotsis (1992) Identification in human urine of a natural growth inhibitor for cells derived from solid pediat-ric tumors. Eur J Clin Invest 22: 260-264.
54. Shida, D., K. Takabe, D. Kapitonov, S. Milstien, S. Spiegel (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9: 662-673.
55. Spiegel, S., S. Milstien (2007) Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282: 2125-2129.
56. Sugiki, H., Y. Hozumi, H. Maeshima, Y. Kataga-ta, Y. Mitsuhashi, S. Kondo (2000) C2-ce-ramide induces apoptosis in a human squa-mous cell carcinoma cell line. Br J Dermatol 143: 1154-1163.
57. Taha, T.A., W. Osta, L. Kozhaya, J. Bielawski, K.R. Johnson, W.E. Gillanders, G.S. Dbaibo, H.A. Hannun, L.M. Obeid (2004) Down regulation of sphingosine kinase-1 by DNA damage. Dependence on proteases and p53. J Biol Chem 279: 20546-20554.
58. Taha, T.A., Y.A. Hannun, L.M. Obeid (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39: 113-131.
59. Vadas, M., P. Xia, G. McCaughan, J. Gamble (2008) The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction? Biochim Biophys Acta 17 81 : 442-447.
60. Van Brocklyn, J.R., C.A. Jackson, D.K. Pearl, M.S. Kotur, P.J. Snyder, T.W. Prior (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblas-toma multiforme: roles of sphingosine ki-nase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64: 695-705.
61. Vogler, R., B. Sauer, D.S. Kim, M. Schäfer-Kort-ing, B. Kleuser (2003) Sphingosine-1-phos-phate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 120: 693-700.
62. Xia, P., J.R. Gamble, L. Wang, S.M. Pitson, P.A. Moretti, B.W. Wattenberg, R.J. D'Andrea, M.A. Vadas (2000) An oncogenic role of sphingosine k inase. Curr Biol 10 : 1527-1530.
63. Xie, X., O.P. Clausen, M. Boysen (20 02) Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 128: 897-902.